Subcutaneous panniculitis-like T-cell lymphoma: Difference between revisions
Line 19: | Line 19: | ||
==Differentiating type page name here from other Diseases== | ==Differentiating type page name here from other Diseases== | ||
Subcutaneous panniculitis-like T-cell lymphoma must be differentiated from other diseases such as: | Subcutaneous panniculitis-like T-cell lymphoma must be differentiated from other diseases such as: | ||
* [[ | * Benign [[panniculitis]] | ||
* [[Cutaneous T-cell lymphoma]] | * [[Cutaneous T-cell lymphoma]] | ||
* [[Extranodal NK | * [[Extranodal NK-T cell lymphoma]] | ||
== Epidemiology and Demographics == | == Epidemiology and Demographics == | ||
===Age=== | ===Age=== |
Revision as of 15:50, 8 March 2016
For patient information, click Insert page name here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Synonyms and keywords:
Overview
Pathophysiology
Associated Conditions
Microscopic Pathology
Causes
There are no established causes for subcutaneous panniculitis-like T-cell lymphoma.
Differentiating type page name here from other Diseases
Subcutaneous panniculitis-like T-cell lymphoma must be differentiated from other diseases such as:
Epidemiology and Demographics
Age
The incidence of subcutaneous panniculitis-like T-cell lymphoma increases with age; the median age at diagnosis is 35 years.
Gender
Females are more commonly affected with subcutaneous panniculitis-like T-cell lymphoma than males.
Risk Factors
There are no established risk factors for subcutaneous panniculitis-like T-cell lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for subcutaneous panniculitis-like T-cell lymphoma.[1]
Natural History, Complications and Prognosis
Diagnosis
Staging
Staging for subcutaneous panniculitis-like T-cell lymphoma is provided in the following table:[2]
Stage | Involvement | Extranodal (E) status |
---|---|---|
Limited | ||
Stage I | One node or a group of adjacent nodes | Single extranodal lesions without nodal involvement |
Stage II | Two or more nodal groups on the same side of the diaphragm | Stage I or II by nodal extent with limited contiguous extranodal involvement |
Stage II bulky | II as above with "bulky" disease | Not applicable |
Advanced | ||
Stage III | Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement | Not applicable |
Stage IV | Additional noncontiguous extralymphatic involvement | Not applicable |
Symptoms
Symptoms of the subcutaneous panniculitis-like T-cell lymphoma include:
- Fever
- Weight loss
- Night sweats
- Painless swelling in the neck, axilla, groin, thorax, and abdomen
Physical Examination
Vitals
- Fever is often present
Skin
- Subcutaneous nodules
HEENT
Thorax
- Thoracic masses suggestive of central lymphadenopathy
Abdomen
- Abdominal masses suggestive of central lymphadenopathy
- Hepatosplenomegaly
Extremities
Laboratory Findings
Laboratory tests for subcutaneous panniculitis-like T-cell lymphoma include:
- Complete blood count (CBC): cytopenia
- Blood chemistry studies: Increased liver function tests
- Cytogenetic analysis
- Flow cytometry
Biopsy
Lymph node or bone marrow biopsy is diagnostic of subcutaneous panniculitis-like T-cell lymphoma.
CT
CT scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
MRI
MRI scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
Other Imaging Findings
PET scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
Treatment
Medical Therapy
Therapy | Description |
---|---|
Chemotherapy |
|
Radiation therapy |
|
Stem cell transplant |
|
References
- ↑ Recommendations. U.S Preventive Services Task Force. Accessed on March 8, 2016
- ↑ Cheson, Bruce D.; Fisher, Richard I.; Barrington, Sally F.; Cavalli, Franco; Schwartz, Lawrence H.; Zucca, Emanuele; Lister, T. Andrew; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute (2014-09-20). "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification". Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 32 (27): 3059–3068. doi:10.1200/JCO.2013.54.8800. ISSN 1527-7755. PMID 25113753.
- ↑ Subcutaneous panniculitis-like T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/subcutaneous-panniculitis-like-t-cell-lymphoma/?region=nb. Accessed on March 8, 2016